US 12,465,521 B2
Hybrid 2-port vitrectomy and combined treatment and infusion probe
Paul R. Hallen, Colleyville, TX (US)
Assigned to Alcon Inc., Fribourg (CH)
Filed by Alcon Inc., Fribourg (CH)
Filed on Apr. 19, 2023, as Appl. No. 18/303,105.
Claims priority of provisional application 63/363,739, filed on Apr. 28, 2022.
Prior Publication US 2023/0346600 A1, Nov. 2, 2023
Int. Cl. A61F 9/008 (2006.01)
CPC A61F 9/008 (2013.01) [A61F 2009/00874 (2013.01)] 11 Claims
OG exemplary drawing
 
1. A surgical instrument for performing an ophthalmic surgical procedure, comprising:
a handpiece; and
a probe at a distal end of the handpiece configured to be inserted into an intraocular space of an eye, the probe comprising:
an infusion portion having a first diameter, the infusion portion comprising:
a port for directing fluid into a surgical site within the intraocular space; and
a channel fluidly coupled to the port for delivering the fluid to the port; and
a treatment portion distal to the infusion portion and having a second diameter smaller than the first diameter, the treatment portion comprising:
a device for treating a tissue at a surgical site, comprising:
a sealed laser probe having a tube with a window press fit into a distal end of the tube;
one or more optical fibers extending down a length of an interior of the sealed laser probe tube to deliver laser light and illumination light through the window and illumination light through a distal side wall of the sealed laser probe tube;
wherein the sealed laser probe tube comprises masking along a majority of a length of the laser probe tube except the distal side wall which comprises at least a ¼ of a length of the laser probe tube extending from the distal end of the sealed laser probe tube.